Life Expectancy and Life Years Lost After HIV Diagnosis in Puerto Rico, 2000-2020

Authors

  • Grisel Burgos-Barreto San Juan Bautista School of Medicine, Caguas, Puerto Rico, 00726 Clinical Skills and Community Engagement Department
  • Daniel Reyes San Juan Bautista School of Medicine, Caguas, Puerto Rico, 00726 Clinical Skills and Community Engagement Department and University of Arizona College of Medicine-Phoenix, Phoenix, Arizona 85004
  • Raymond L Tremblay San Juan Bautista School of Medicine, Caguas, Puerto Rico, 00726 Clinical Skills and Community Engagement Department

DOI:

https://doi.org/10.14738/bjhmr.111.16347

Keywords:

Life Years Lost, HIV/AIDS, Life Expectancy, Puerto Rico, AIDS, Acquired Immunodeficiency Syndrome, ART, Antiretroviral Therapy, AYLL: Average Years of Life Lost, EMA: Eligible Metropolitan Area, HIV: Human Immunodeficiency Virus, LGB: Lesbian, Gay and Bisexual, MSM: men who have sex with men, IDU: intravenous drug use, LYL: Life Years Lost, PR: Puerto Rico

Abstract

Background:  In 2019, the Global Burden of Disease estimated that HIV/AIDS was globally the second top cause for disability-adjusted life years in individuals 25–49 years of age and the ninth most common cause for young individuals between the ages of 10-24. The objective of this study was to estimate the average life expectancy and life years lost (LYL) in individuals diagnosed with HIV in Puerto Rico from 2000-2020 and to evaluate the relationship between LYL and demographic factors. Methods: The epidemiological design was a retrospective cohort study of 11,524 people diagnosed with HIV who received services under the Eligible Metropolitan Area (EMA) of San Juan, Puerto Rico. The population among this cohort was described using socioeconomic characteristics with frequencies and proportions by category. We estimated the LYL by matching the expected residual lifetime for someone diagnosed with the disease with the life expectancy of the general population at that specific age as the null model. Results: LYL is greater with earlier HIV onset and is also influenced by level of poverty, type of insurance, and documented mode of transmission of HIV. The average life expectancy (number of years alive remaining after diagnosis) across all ages of an HIV-diagnosed individual is between 12 and 14 years. We found greater LYL in HIV patients with lower income status across age groups; in those without insurance, significantly in ages of 40-49 years; as well as with perinatal transmission versus other modes of transmission, and intravenous drug use versus heterosexual contact. No distinction was found between males versus females. Conclusion: This study reaffirms the importance of prevention and demographic aspects such as age, poverty level, insurance type, and factors related to lifestyle (transmission modes) to develop better prevention strategies to reduce the LYL as a consequence of HIV.

References

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1204–22. Epub 2020/10/19. doi: 10.1016/S0140-6736(20)30925-9.

Sauce, D., Pourcher, V., Ferry, T., Boddaert, J., Slama, L., Allavena, C. Immune activation and chronic inflammation: Is there an additional effect of HIV in a geriatric population? Medicine (Baltimore). 2021 Apr 30;100(17).

Andersen PK. Life years lost among patients with a given disease. Stat Med. 2017; 36:3573–3582. https://doi.org/10.1002/sim.7357 PMID: 28585255.

Andersen PK, Canudas-Romo V, Keiding N. Cause-specific measures of life years lost. Demogr Res. 2013; 29: 1127–1152. https://doi.org/10.4054/DemRes.2013.29.41.

Plana-Ripoll, O., Canudas-Romo, V., Weye, N., Laursen, T. M., McGrath, J. J., & Andersen, P. K. lillies: An R package for the estimation of excess Life Years Lost among patients with a given disease or condition. PloS one. 2020; 15(3), e0228073. https://doi.org/10.1371/journal.pone.0228073.

Lebanova, H., Stoev, S., Naseva, E., Getova, V., Wang, W., Sabale, U., & Petrova, E.. Economic Burden of Cervical Cancer in Bulgaria. International Journal of Environmental Research and Public Health. 2023; 20(3), 2746.

Dreier, J. W., Laursen, T. M., Tomson, T., Plana-Ripoll, O., & Christensen, J. Cause-specific mortality and life years lost in people with epilepsy: a Danish cohort study. Brain. 2023; 146(1), 124-134.

Ruffieux, Y., Wettstein, A., Maartens, G., Folb, N., Mesa Vieira, C., Didden, C., Haas, A. D. Life-years lost associated with mental illness: a cohort study of beneficiaries of a South African medical insurance scheme. medRxiv. 2023-01.

Chudasama YV, Khunti K, Gillies CL, Dhalwani NN, Davies MJ, Yates T, Zaccardi F. Estimates of years of life lost depended on the method used: tutorial and comparative investigation. J Clin Epidemiol. 2022 Oct; 150:42-50. doi: 10.1016/j.jclinepi.2022.06.012. Epub 2022 Jun 24. PMID: 35760239.

Salama, A. K., Rosa, N.d, Scheri, R. P., Herndon, J. E., Tyler, D. S., Marcello, J., Pruitt, S. K., & Abernethy, A. P. The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost. Cancer investigation, 2012; 30(9), 637–641. https://doi.org/10.3109/07357907.2012.726387.

Yaghoobi, H., Ahmadinia, H., Shabani, Z., Vazirinejad, R., Safari, R., Shahizadeh, R., Zolfizadeh, F., & Rezaeian, M. Life expectancy and years of life lost in HIV patients under the care of BandarAbbas Behavioral Disorders Counseling Center. Nepal journal of epidemiology, 2017; 7(4), 702–712. https://doi.org/10.3126/nje.v7i4.20627.

Siddiqi, A., Hall, H. I., Hu, X. & Song, R. Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008-2011. JAIDS Journal of Acquired Immune Deficiency Syndromes, 2016; 72 (2), 230-236. Doi: 10.1097/QAI.0000000000000960.

Singh GK, Lee H. Marked Disparities in Life Expectancy by Education, Poverty Level, Occupation, and Housing Tenure in the United States, 1997-2014. Int J MCH AIDS. 2021;10(1):7-18. doi: 10.21106/ijma.402. Epub 2020 Dec 30. PMID: 33442488; PMCID: PMC7792745.

Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP Jr, Klein DB, Towner WJ, Horberg MA, Silverberg MJ. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals with Access to Care. J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):39-46. doi: 10.1097/QAI.0000000000001014. PMID: 27028501; PMCID: PMC5427712.

Burgos-Barreto G, Reyes D, Tremblay R. Life Expectancy and Life Years Lost After HIV or AIDS Diagnosis: A Retrospective Cohort Study. International Journal of Current Science Research and Review; 6(4), 2409-2416.

Pesquera FM. Tablas de vida abreviadas para Puerto Rico. 1999-2002 a 2008-2010. Estado Libre Asociado de Puerto Rico, Departamento de Salud, Secretaría Auxiliar de Planificación y desarrollo. 2013. www.salud.gov.pr. Accessed March 20, 2023.

Erlangsen A, Andersen PK, Toender A, Laursen TM, Nordentoft M, & Canudas-Romo V. Cause-specific life-years lost in people with mental disorders: a nationwide, register-based cohort study. The lancet. Psychiatry. 2017; 4(12), 937–945. https://doi.org/10.1016/S2215-0366(17)30429-7.

Plana-Ripoll, O. lillies: Estimation of Life Years Lost. R package version 0.2.9. 2021. https://CRAN.R-project.org/package=lillies.

Wickham H, Averick M, Bryan J, Chang W, McGowan LD, François R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen TL, Miller E, Bache SM, Müller K, Ooms J, Robinson D, Seidel DP, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H. “Welcome to the tidyverse.” Journal of Open-Source Software. 2019; *4*(43), 1686. doi:10.21105/joss.01686 https://doi.org/10.21105/joss.01686.

Poverty Guidelines. Assistant Secretary for Planning and Evaluation. Updated 2023. Accessed Jul 29, 2023. https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines.

Harrison, KM, Song R, & Zhang X. Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2010; 53 (1), 124-130. Doi: 10.1097/QAI.0b013e3181b563e7.

Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS Statistics — 2022 Fact Sheet. 2022. https://www.unaids.org/en/resources/fact-sheet. Accessed March 25, 2023.

Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, Lam JO, Towner WJ, Yuan Q, Horberg MA, Silverberg MJ. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults with and Without HIV Infection, 2000-2016. JAMA Netw Open. 2020 Jun 1;3(6): e207954. doi: 10.1001/jamanetworkopen. 2020; 7954. PMID: 32539152; PMCID: PMC7296391.

Marcus J. Increased Overall Life Expectancy but Not Comorbidity-Free Years for People with HIV, Conference on Retroviruses and Opportunistic Infections (CROI). March 8-11, 2020. Boston. Abstract 151. croiconference.org/sessions/increased-overall-life-expectancy-not-comorbidity-free-years-people-hiv.

Singh GK, Azuine RE, Siahpush M. Widening Socioeconomic, Racial, and Geographic Disparities in HIV/AIDS Mortality in the United States, 1987-2011. Adv Prev Med. 2013; 2013:657961. doi:10.1155/2013/657961.

Downloads

Published

2024-02-10

How to Cite

Burgos-Barreto, G., Reyes, D., & Tremblay, R. L. (2024). Life Expectancy and Life Years Lost After HIV Diagnosis in Puerto Rico, 2000-2020. British Journal of Healthcare and Medical Research, 11(1), 180–194. https://doi.org/10.14738/bjhmr.111.16347